美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=PALIPERIDONE PALMITATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
PALIPERIDONE PALMITATE 211149 001 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 39MG/0.25ML (39MG/0.25ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Discontinued
PALIPERIDONE PALMITATE 211149 002 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 78MG/0.5ML (78MG/0.5ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Discontinued
PALIPERIDONE PALMITATE 211149 003 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 117MG/0.75ML (117MG/0.75ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Discontinued
PALIPERIDONE PALMITATE 211149 004 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 156MG/ML (156MG/ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Discontinued
PALIPERIDONE PALMITATE 211149 005 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 234MG/1.5ML (156MG/ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Discontinued
PALIPERIDONE PALMITATE 211995 001 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 39MG/0.25ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 211995 002 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 78MG/0.5ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 211995 003 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 117MG/0.75ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 211995 004 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 156MG/ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 211995 005 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 234MG/1.5ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database